合計 50 件の最近のインサイダー取引記録が記録されています Cellectar Biosciences, Inc. (CLRB), 内訳は 46 件の買い および 3 件の売り. インサイダー買い総額は $8.96M インサイダー売り総額は $731.99.
最近活動のある主要インサイダーには Neis John, Caruso James V, Longcor Jarrod. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — CLRB
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2025-12-12 |
Neis John |
Director |
情報に基づく売り |
198 |
$3.70 |
$731.99 |
10 |
| 2025-07-02 |
Caruso James V |
Chief Executive Officer |
情報に基づく買い |
10,000 |
$5.25 |
$52.5K |
10,000 |
| 2025-07-02 |
Longcor Jarrod |
Chief Operating Officer |
情報に基づく買い |
10,000 |
$5.25 |
$52.5K |
10,000 |
| 2025-07-02 |
Kolean Chad J |
Chief Financial Officer |
情報に基づく買い |
5,000 |
$5.25 |
$26.25K |
5,000 |
| 2025-02-14 |
Driscoll Frederick W |
Director |
RSU 付与（制限付株式） |
60,000 |
$0.29 |
$17.4K |
60,000 |
| 2025-02-14 |
Neis John |
Director |
RSU 付与（制限付株式） |
60,000 |
$0.29 |
$17.4K |
60,000 |
| 2025-02-14 |
Caruso James V |
President and CEO |
RSU 付与（制限付株式） |
900,000 |
$0.29 |
$261K |
900,000 |
| 2025-02-14 |
Swirsky Douglas J |
Director |
RSU 付与（制限付株式） |
90,000 |
$0.29 |
$26.1K |
90,000 |
| 2025-02-14 |
Loren Stefan |
Director |
RSU 付与（制限付株式） |
60,000 |
$0.29 |
$17.4K |
60,000 |
| 2025-02-14 |
Longcor Jarrod |
Chief Operating Officer |
RSU 付与（制限付株式） |
500,000 |
$0.29 |
$145K |
500,000 |
| 2025-02-14 |
Kolean Chad J |
Chief Financial Officer |
RSU 付与（制限付株式） |
290,000 |
$0.29 |
$84.1K |
290,000 |
| 2025-02-14 |
Chanan-khan Asher |
Director |
RSU 付与（制限付株式） |
60,000 |
$0.29 |
$17.4K |
60,000 |
| 2025-01-10 |
Longcor Jarrod |
Chief Operating Officer |
情報に基づく買い |
30,000 |
$0.28 |
$8.4K |
83,141 |
| 2024-06-14 |
Driscoll Frederick W |
Director |
RSU 付与（制限付株式） |
60,000 |
$2.58 |
$154.8K |
60,000 |
| 2024-06-14 |
Neis John |
Director |
RSU 付与（制限付株式） |
60,000 |
$2.58 |
$154.8K |
60,000 |
| 2024-06-14 |
Caruso James V |
President and CEO |
RSU 付与（制限付株式） |
900,000 |
$2.65 |
$2.39M |
900,000 |
| 2024-06-14 |
Swirsky Douglas J |
Director |
RSU 付与（制限付株式） |
90,000 |
$2.58 |
$232.2K |
90,000 |
| 2024-06-14 |
Loren Stefan |
Director |
RSU 付与（制限付株式） |
60,000 |
$2.58 |
$154.8K |
60,000 |
| 2024-06-14 |
Longcor Jarrod |
Chief Operating Officer |
RSU 付与（制限付株式） |
500,000 |
$2.65 |
$1.33M |
500,000 |
| 2024-06-14 |
Kolean Chad J |
Chief Financial Officer |
RSU 付与（制限付株式） |
290,000 |
$2.65 |
$768.5K |
290,000 |
| 2024-06-14 |
Chanan-khan Asher |
Director |
RSU 付与（制限付株式） |
60,000 |
$2.58 |
$154.8K |
60,000 |
| 2024-06-14 |
Lea Darrell Shane |
Chief Commercial Officer |
RSU 付与（制限付株式） |
260,000 |
$2.65 |
$689K |
260,000 |
| 2024-06-14 |
Shustov Andrei |
Senior Vice President, Medical |
RSU 付与（制限付株式） |
260,000 |
$2.65 |
$689K |
260,000 |
| 2023-12-08 |
Caruso James V |
President and CEO |
RSU 付与（制限付株式） |
40,596 |
- |
- |
49,236 |
| 2023-12-08 |
Longcor Jarrod |
Chief Operating Officer |
RSU 付与（制限付株式） |
42,927 |
- |
- |
53,141 |
| 2023-12-08 |
Kolean Chad J |
Chief Financial Officer |
RSU 付与（制限付株式） |
42,554 |
- |
- |
42,578 |
| 2023-12-08 |
Lea Darrell Shane |
Chief Commercial Officer |
RSU 付与（制限付株式） |
39,599 |
- |
- |
39,599 |
| 2023-12-08 |
Shustov Andrei |
Senior Vice President, Medical |
RSU 付与（制限付株式） |
47,856 |
- |
- |
55,038 |
| 2023-06-28 |
Driscoll Frederick W |
Director |
RSU 付与（制限付株式） |
25,000 |
$1.85 |
$46.25K |
47,650 |
| 2023-06-28 |
Neis John |
Director |
RSU 付与（制限付株式） |
25,000 |
$1.85 |
$46.25K |
47,887 |
| 2023-06-28 |
Swirsky Douglas J |
Director |
RSU 付与（制限付株式） |
37,500 |
$1.85 |
$69.38K |
71,925 |
| 2023-06-28 |
Loren Stefan |
Director |
RSU 付与（制限付株式） |
25,000 |
$1.85 |
$46.25K |
47,885 |
| 2023-06-28 |
Chanan-khan Asher |
Director |
RSU 付与（制限付株式） |
25,000 |
$1.85 |
$46.25K |
40,600 |
| 2023-06-23 |
Caruso James V |
President and CEO |
RSU 付与（制限付株式） |
261,000 |
$1.68 |
$438.48K |
261,000 |
| 2023-06-23 |
Longcor Jarrod |
Chief Operating Officer |
RSU 付与（制限付株式） |
144,000 |
$1.68 |
$241.92K |
144,000 |
| 2023-06-23 |
Kolean Chad J |
Chief Financial Officer |
RSU 付与（制限付株式） |
104,000 |
$1.68 |
$174.72K |
104,000 |
| 2023-06-23 |
Lea Darrell Shane |
Chief Commercial Officer |
RSU 付与（制限付株式） |
100,000 |
$1.68 |
$168K |
100,000 |
| 2023-02-15 |
Shustov Andrei |
Senior Vice President, Medical |
処分 |
- |
- |
- |
7,182 |
| 2023-02-15 |
Shustov Andrei |
Senior Vice President, Medical |
RSU 付与（制限付株式） |
100,000 |
$1.67 |
$167K |
100,000 |
| 2023-01-17 |
Caruso James V |
President and CEO |
RSU 付与（制限付株式） |
261,000 |
- |
- |
261,000 |
| 2023-01-17 |
Longcor Jarrod |
Chief Operating Officer |
RSU 付与（制限付株式） |
144,000 |
- |
- |
144,000 |
| 2023-01-17 |
Kolean Chad J |
Chief Financial Officer |
RSU 付与（制限付株式） |
104,000 |
- |
- |
104,000 |
| 2022-11-21 |
Lea Darrell Shane |
Officer |
不明 |
- |
- |
- |
- |
| 2022-11-21 |
Lea Darrell Shane |
Chief Commercial Officer |
RSU 付与（制限付株式） |
100,000 |
- |
- |
100,000 |
| 2022-06-24 |
Driscoll Frederick W |
Director |
RSU 付与（制限付株式） |
7,800 |
- |
- |
7,800 |
| 2022-06-24 |
Neis John |
Director |
RSU 付与（制限付株式） |
7,800 |
- |
- |
7,800 |
| 2022-06-24 |
Swirsky Douglas J |
Director |
RSU 付与（制限付株式） |
11,700 |
$4.10 |
$47.97K |
11,700 |
| 2022-06-24 |
Loren Stefan |
Director |
RSU 付与（制限付株式） |
7,800 |
$4.10 |
$31.98K |
7,800 |
| 2022-06-24 |
Chanan-khan Asher |
Director |
RSU 付与（制限付株式） |
7,800 |
- |
- |
7,800 |
| 2022-02-24 |
Kolean Chad J |
Chief Financial Officer |
処分 |
- |
- |
- |
240 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
